Form 8-K · Current report
GE HealthCare 8-K, filed Sep 22, 2026
- Filed
- CIK
- 0001932393
- Accession no.
- 0001932393-26-000053
Summary
GE HealthCare Technologies Inc. appointed Pascal Desroches to its board of directors effective January 4, 2027, and named him to the Audit Committee and the Talent, Culture, and Compensation Committee effective the same date. Desroches will receive non-employee director compensation under the company's existing program and will enter into an indemnification agreement; the company said there is no arrangement or understanding with any other person regarding his selection and no transactions reportable under Item 404(a) of Regulation S-K.
Key points
- The appointment of Pascal Desroches as a director takes effect January 4, 2027.
- He will also join the Audit Committee and the Talent, Culture, and Compensation Committee on January 4, 2027.
- He will receive compensation under GE HealthCare's non-employee director program and an indemnification agreement.
- GE HealthCare issued a press release announcing the appointment on September 22, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 22, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Pascal Desroches to serve as a director of the Company, effective January 4, 2027. The Board also appointed Mr. Desroches as a member of the Audit Committee and the Talent, Culture, and Compensation Committee of the Board, effective January 4, 2027. Upon joining the Board, Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.